Financial News
Beam Therapeutics Inc (NQ: BEAM )
26.26
+0.32
(+1.23%)
Streaming Delayed Price
Updated: 11:28 AM EDT, Jul 22, 2024
Add to My Watchlist
All News about Beam Therapeutics Inc
![](https://g.foolcdn.com/editorial/images/713736/nurse-and-doctors-in-masks-discussing-chart.jpg)
4 Analysts Have This to Say About Beam Therapeutics
December 20, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/20/aapharma_11.png?width=1200&height=800&fit=crop)
BMO Capital Upgrades Beam Therapeutics: Here's What You Need To Know
December 20, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/20/image-tesla3.jpg?width=1200&height=800&fit=crop)
Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday
December 20, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/02/rocket-launch-clouds-space.png)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3869.jpeg?width=1200&height=800&fit=crop)
Beam Therapeutics's Return On Capital Employed Insights
November 30, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/07/aapharma_6.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/708168/red-arrow.jpg)
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
December 20, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
From Beam Therapeutics
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_2562.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
December 13, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/02/image31.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/709830/mfm_20221116.jpg)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/image14.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
Beam Therapeutics to Participate in Upcoming Investor Conferences
November 09, 2022
From Beam Therapeutics
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/07/image-treehouse_foods.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/08/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/analysis-g83ed89eb5_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/image14.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/image-global_payments.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/10/A1MAIN_GeneEdit_102122.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.